Boardroom Alpha
Boardroom Alpha
BLCO · Current Report (Form 8-K) · Filed November 13, 2025

Bausch & Lomb Corp — Current Report (Form 8-K)

Form
8-K
Filed
November 13, 2025
Period
Nov 13, 2025
Ticker
BLCO
Accession
0000950103-25-014656
Boardroom Alpha · Filing insights

Bausch + Lomb announces Investor Day details and reaffirmed FY2025 guidance; three-year targets and pipeline to be discussed.

About Bausch & Lomb Corp
Market cap
$5.3B
1Y TSR
+33.2%
3Y TSR
−5.7%
Board grade
C+
Sector
Healthcare
CEO
Brent L Saunders
Last annual meeting: May 20, 2026 · View full Bausch & Lomb Corp profile →

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

November 13, 2025

Date of Report (Date of the earliest event reported)

 

 

Bausch + Lomb Corporation

(Exact Name of Registrant as Specified in Its Charter)

 

 

Canada 001-41380 98-1613662

(State or Other Jurisdiction of

Incorporation or Organization)

(Commission

File Number)

(I.R.S. Employer

Identification Number)

 

520 Applewood Crescent

Vaughan, Ontario

Canada L4K 4B4

(Address of Principal Executive Offices)(Zip Code)

 

(905) 695-7700

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Shares, No Par Value BLCO New York Stock Exchange Toronto Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

Item 7.01Regulation FD Disclosure.

 

On November 13, 2025, Bausch + Lomb Corporation (the “Company”) issued a press release announcing certain information that will be discussed during its upcoming Investor Day, to be held on November 13, 2025, including certain three-year financial targets, the details of certain pipeline products and the re-affirmation of the Company’s previously announced guidance for the fiscal year ending December 31, 2025. On November 13, 2025, the Company also posted a slide presentation to its website, which provided further details on the items to be discussed at its upcoming Investor Day. A copy of the press release is attached as Exhibit 99.1 to this report and a copy of the slide presentation is attached as Exhibit 99.2 to this report, both of which exhibits are incorporated herein by this reference. Interested persons can access the webcast, and a replay of the webcast will be available, on the Investor Relations section of the Bausch + Lomb website.

 

The information in this Item 7.01, including Exhibit 99.1 and Exhibit 99.2, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Item 7.01 and Exhibit 99.1 and Exhibit 99.2 shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.

 

Item 9.01.Financial Statements and Exhibits.

 

(d)Exhibits

 

Exhibit No.   Description

99.1*

  Press Release of Bausch + Lomb Corporation, respecting its Investor Day, dated November 13, 2025

99.2*

  Slide Presentation of Bausch + Lomb Corporation, respecting its Investor Day, dated November 13, 2025

104*

 

Cover Page Interactive Data File (formatted as Inline XBRL)

____________________________________

* Filed herewith.

 

 

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  BAUSCH + LOMB CORPORATION
     
  By: /s/ Sam Eldessouky
  Name: Sam Eldessouky
  Title: Executive Vice President, Chief Financial Officer

 

Date: November 13, 2025

 

 

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Bausch & Lomb Corp (BLCO)

Reference

Frequently asked questions

When did Bausch & Lomb Corp file this 8-K?
Bausch & Lomb Corp (BLCO) filed this Current Report (Form 8-K) with the SEC on November 13, 2025. The accession number assigned by EDGAR is 0000950103-25-014656.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Bausch + Lomb announces Investor Day details and reaffirmed FY2025 guidance; three-year targets and pipeline to be discussed. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Bausch & Lomb Corp's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Bausch & Lomb Corp has filed under CIK 1860742, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer